Atara Biotherapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Atara Biotherapeutics, Inc. on September 21, 2015, covering an event that occurred on September 18, 2015. The filing addresses a change in the composition of the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance matters and does not contain financial performance data.
Material Changes
On September 18, 2015, Eckard Weber, M.D., resigned from the Board of Directors, effective immediately. Dr. Weber was a partner with Domain Associates, LLC, and served as a member of the Compensation Committee at the time of his departure. The Company stated that the resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies beyond the specific event of the director's resignation.
Key Facts for Investor Verification
- Dr. Eckard Weber resigned from the Board of Directors and the Compensation Committee effective September 18, 2015.
- The resignation was voluntary and not due to any disagreement with the Company.
- Dr. Weber is a partner with the venture capital firm Domain Associates, LLC.
- No financial data or operational updates are included in this specific filing.